Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$32.09 - $37.51 $44,926 - $52,514
-1,400 Reduced 14.32%
8,378 $278,000
Q2 2023

Aug 14, 2023

BUY
$36.12 - $41.79 $148,092 - $171,339
4,100 Added 72.21%
9,778 $359,000
Q1 2023

May 15, 2023

SELL
$39.39 - $51.28 $7,917 - $10,307
-201 Reduced 3.42%
5,678 $232,000
Q4 2021

Feb 14, 2022

BUY
$41.32 - $61.25 $4,132 - $6,125
100 Added 1.73%
5,879 $347,000
Q3 2021

Nov 15, 2021

BUY
$39.25 - $50.42 $11,539 - $14,823
294 Added 5.36%
5,779 $249,000
Q2 2021

Aug 17, 2021

BUY
$35.91 - $40.68 $196,966 - $223,129
5,485 New
5,485 $215,000
Q1 2021

May 17, 2021

SELL
$33.49 - $37.77 $220,163 - $248,299
-6,574 Closed
0 $0
Q4 2020

Feb 17, 2021

BUY
$33.47 - $42.56 $200 - $255
6 Added 0.09%
6,574 $242,000
Q3 2020

Nov 16, 2020

BUY
$31.75 - $37.25 $158 - $186
5 Added 0.08%
6,568 $241,000
Q2 2020

Aug 14, 2020

BUY
$30.12 - $36.54 $180 - $219
6 Added 0.09%
6,563 $215,000
Q1 2020

May 15, 2020

BUY
$27.03 - $38.62 $135 - $193
5 Added 0.08%
6,557 $214,000
Q4 2019

Feb 18, 2020

SELL
$32.92 - $37.36 $6,419 - $7,285
-195 Reduced 2.89%
6,552 $257,000
Q3 2019

Nov 14, 2019

BUY
$32.49 - $42.13 $162 - $210
5 Added 0.07%
6,747 $242,000
Q2 2019

Aug 14, 2019

SELL
$36.98 - $41.52 $71,001 - $79,718
-1,920 Reduced 22.17%
6,742 $292,000
Q1 2019

May 16, 2019

BUY
$37.5 - $41.2 $150 - $164
4 Added 0.05%
8,662 $368,000
Q4 2018

Feb 15, 2019

BUY
$38.47 - $43.86 $115 - $131
3 Added 0.03%
8,658 $378,000
Q4 2017

Feb 15, 2018

SELL
$33.26 - $35.29 $75,533 - $80,143
-2,271 Reduced 20.79%
8,655 $313,000
Q3 2017

Nov 14, 2017

BUY
$31.0 - $34.15 $338,706 - $373,122
10,926
10,926 $390,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track First Wilshire Securities Management Inc Portfolio

Follow First Wilshire Securities Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Wilshire Securities Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on First Wilshire Securities Management Inc with notifications on news.